Panion & BF Biotech Strengthens Specialty Drug Portfolio with Licensing Agreement for Future ED Drug Technology

On the 12th, Panion & BF Biotech announced that, as part of its strategy to expand its specialty drug portfolio, it will sign an exclusive licensing agreement with Future Drug Development & Biomedical. Through this agreement, Panion & BF Biotech will obtain exclusive rights in Taiwan to key patented technologies developed by Future Drug for the treatment of erectile dysfunction (ED), along with the preferential exclusive negotiation rights for licensing in China, Hong Kong, and Macau. The licensing deal covers the full value chain, including research and development, registration, manufacturing, sales, and marketing.